These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2653391)

  • 41. Flosequinan for heart failure.
    Med Lett Drugs Ther; 1993 Mar; 35(892):23-4. PubMed ID: 8441362
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flosequinan for chronic heart failure?
    Drug Ther Bull; 1993 Jun; 31(12):47-8. PubMed ID: 8344139
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of flosequinan, given over 3 days, evaluated by continuous hemodynamic monitoring.
    Schneeweiss A; Plich M; Green T; Wynne RD; Marmor A
    Cardiology; 1989; 76(3):201-5. PubMed ID: 2776141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
    Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flosequinan: a new vasodilator for the treatment of heart failure.
    Dutka DP; Cleland JG
    Br J Hosp Med; 1993 May 5-18; 49(9):654-5. PubMed ID: 8508260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flosequinan for congestive heart failure: what promise does it hold?
    Hampton JR
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1313-5. PubMed ID: 2278865
    [No Abstract]   [Full Text] [Related]  

  • 49. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
    Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
    Condorelli M; Bonaduce A; Montemurro A; Mattioli G; Cappello C; Caponnetto S; Terrachini V; Canale C; Varricchio M; Cacciapuoti F
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S83-92. PubMed ID: 2483445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enalapril for severe congestive heart failure. A double-blind study.
    Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J
    Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flosequinan in heart failure.
    Haynes WG; Webb DJ
    Lancet; 1993 Apr; 341(8852):1100-1. PubMed ID: 8097003
    [No Abstract]   [Full Text] [Related]  

  • 54. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
    Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol. A pilot study in healthy subjects.
    Ng HW; Walley TJ; Tsao Y; Breckenridge AM
    Eur J Clin Pharmacol; 1994; 46(4):361-5. PubMed ID: 7957523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure.
    Kholeif MA; Pringle S; Kesson E; Murray G; Kennedy JA; Lorimer AR; Stock JK; Brown JJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S180-3. PubMed ID: 1725036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitrate therapy for congestive heart failure.
    Franciosa JA; Nordstrom LA; Cohn JN
    JAMA; 1978 Aug; 240(5):443-6. PubMed ID: 351232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.